ArticleJournal of translational medicine2003

Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial.

Michele Guida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.